5AM Venture Management’s IDEAYA Biosciences IDYA Stock Holding History

5AM Venture Management’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-868,520	Closed	-$11.9M	–	26
2023 Q1	$11.9M	Sell	868,520 -327,778	-27%	-$5.46M	3.05%	7
2022 Q4	$21.7M	Hold	1,196,298	–	–	5.84%	5
2022 Q3	$17.8M	Sell	1,196,298 -201,768	-14%	-$2.62M	3.42%	8
2022 Q2	$19.3M	Hold	1,398,066	–	–	4.77%	8
2022 Q1	$15.6M	Hold	1,398,066	–	–	3.42%	12
2021 Q4	$33M	Hold	1,398,066	–	–	6.2%	6
2021 Q3	$35.6M	Sell	1,398,066 -400,000	-22%	-$9.34M	7.24%	5
2021 Q2	$37.7M	Hold	1,798,066	–	–	9.5%	3
2021 Q1	$42.3M	Hold	1,798,066	–	–	7.61%	4
2020 Q4	$25.2M	Sell	1,798,066 -1,665,000	-48%	-$22.6M	8.48%	5
2020 Q3	$43.5M	Hold	3,463,066	–	–	11.44%	4
2020 Q2	$49.2M	Hold	3,463,066	–	–	10.78%	4
2020 Q1	$14.3M	Hold	3,463,066	–	–	4.42%	7
2019 Q4	$26M	Buy	+3,463,066	New	+$24.7M	5.59%	6

Other funds holding IDYA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CPX

Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

5AM Venture Management's IDYA Position: Q2 2023 in Review

5AM Venture Management sold out of IDEAYA Biosciences (IDYA) in Q2 2023, closing a stake of 868,520 shares — an estimated $11.9M sold.

5AM Venture Management first reported a position in IDYA in Q4 2019 and held it in 14 quarters. The position peaked at $49.2M in Q2 2020. 138 funds tracked by Wall St. Rank hold IDYA as of Q2 2023.

5AM Venture Management reported no remaining IDEAYA Biosciences position as of Q2 2023 after selling out during the quarter.
5AM Venture Management sold 868,520 IDEAYA Biosciences shares in Q2 2023, an estimated $11.9M.
5AM Venture Management first reported a position in IDEAYA Biosciences in Q4 2019 and held it in 14 quarters.
5AM Venture Management's IDEAYA Biosciences position peaked at $49.2M in Q2 2020.
138 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2023.

Based on 5AM Venture Management's 13F filing for Q2 2023, filed 14 Aug 2023.